However, it is important to note that EGFR mutation prevalence in NSCLC varies considerably across different ethnic groups. In our study, we report a prevalence rate of 31.1% EGFR mutation in adenocarcinoma. The gene discussed is EGFR; the disease is adenocarcinoma.